Report Highlights
The global telehospital/clinic and telehome market reached $16.3 billion in 2013 and $19.2 billion in 2014, and should reach about $43.4 billion in 2019 with a compound annual growth (CAGR) of 17.7% through 2019.
Report Includes
- An in-depth analysis of the global telemedicine market.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compounds annual growth rates (CAGRs) through 2019.
- Coverage of telemedicine hardware providers, software providers, telecom and networking companies, healthcare companies, health insurance providers, and many more.
- Explorations into the ways in which collaborative healthcare can be better and more economically implemented through telemedicine.
- Examination of the new technological developments as well as the latest business trends developing in the telemedicine market.
- Comprehensive company profiles of key players in the market.
Report Scope
This report focuses on global markets for telemedicine technologies and services. The discussion is organized into 13 chapters and three appendices, as shown below:
- Introduction.
- Summary.
- Telemedicine Overview.
- Telemedicine Technologies and Global Markets (including analysis of key patents).
- Telemedicine Applications.
- Economics of Telemedicine.
- Stakeholders: Opportunities Analysis.
- Consolidation and Ownership Trends.
- North American Markets.
- EU Markets.
- Japanese Market.
- Other Geographical Markets.
- Conclusions.
- Appendices.
- Appendix A: Company Profiles.
- Appendix B: List of Telemedicine Programs Studied.
- Appendix C: Acronyms.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Report Highlights
The global telehome and telemedicine market reached $13.8 billion 2012. This market is expected to grow to $16.1 billion 2013 and $35.1 billion in 2018 with a compound annual growth (CAGR) of 16.9%.
Report Includes
- An in-depth analysis of the global telemedicine market.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compounds annual growth rates (CAGRs) through 2018.
- Coverage of telemedicine hardware providers, software providers, telecom and networking companies, healthcare companies, health insurance providers, and many more.
- Explorations into the ways in which collaborative healthcare can be better and more economically implemented through telemedicine.
- Examination of the new technological developments as well as the latest business trends developing in the telemedicine market.
- Comprehensive company profiles of key players in the market.
Report Highlights
The global telemedicine market is expected to grow from $9.8 billion in 2010 to $11.6 billion in 2011, and to $27.3 billion in 2016, a compound annual growth rate (CAGR) of 18.6% over the next five years.
Report Highlights
The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015, at a compound annual growth rate (CAGR) of 18.6% over the next 5 years.
Report Highlights
-
The global market for telemedicine increased from $4.8 billion in 2006 to an estimated $5.8 billion in 2007. It should reach $13.9 billion by 2012, a compound annual growth rate (CAGR) of 19%.
-
The telehome market currently accounts for 22% of the market and is expected to capture almost 37% of the telemedicine market by 2012.
-
The telemedicine service market is expected to grow from $3.6 billion in 2007 to $8.3 billion in 2012, mainly driven by the telehospital service market.
Report Highlights
-
The current level of telemedicine expenditures is about $4.33 billion.
-
These expenditures will experience an AAGR of 9.7% from 2002 to 2007.
-
Procurement will continue to be the lead spending category through 2007.
-
In 2007, it will account for a total of $2.16 billion, or about 31% of all spending.
-
Fastest growth in technology spending will be software, at an AAGR of 12.9%.
Related Reports
Digital Pathology: Technologies and Global Markets
The global digital pathology market totaled nearly $2.1 billion in 2012. This market is expected to grow at a compound annual growth rate (CAGR) of 14.7% from $2.2 billion in 2013 to nearly $4.5 billion in 2018.
Top Ten Companies in Telemedicine Technologies
The goal of this document is to provide a more in-depth look at the top-tier telemedicine companies as well as some of the second-tier companies to look for in the near future.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More